全文获取类型
收费全文 | 10565篇 |
免费 | 1179篇 |
国内免费 | 544篇 |
专业分类
耳鼻咽喉 | 98篇 |
儿科学 | 262篇 |
妇产科学 | 227篇 |
基础医学 | 2104篇 |
口腔科学 | 551篇 |
临床医学 | 506篇 |
内科学 | 1154篇 |
皮肤病学 | 109篇 |
神经病学 | 132篇 |
特种医学 | 171篇 |
外国民族医学 | 3篇 |
外科学 | 1235篇 |
综合类 | 1586篇 |
现状与发展 | 3篇 |
预防医学 | 274篇 |
眼科学 | 1490篇 |
药学 | 1076篇 |
2篇 | |
中国医学 | 251篇 |
肿瘤学 | 1054篇 |
出版年
2024年 | 17篇 |
2023年 | 169篇 |
2022年 | 215篇 |
2021年 | 461篇 |
2020年 | 359篇 |
2019年 | 357篇 |
2018年 | 380篇 |
2017年 | 415篇 |
2016年 | 430篇 |
2015年 | 462篇 |
2014年 | 607篇 |
2013年 | 732篇 |
2012年 | 597篇 |
2011年 | 642篇 |
2010年 | 582篇 |
2009年 | 498篇 |
2008年 | 625篇 |
2007年 | 558篇 |
2006年 | 529篇 |
2005年 | 457篇 |
2004年 | 424篇 |
2003年 | 348篇 |
2002年 | 258篇 |
2001年 | 266篇 |
2000年 | 207篇 |
1999年 | 169篇 |
1998年 | 158篇 |
1997年 | 158篇 |
1996年 | 103篇 |
1995年 | 106篇 |
1994年 | 96篇 |
1993年 | 123篇 |
1992年 | 83篇 |
1991年 | 93篇 |
1990年 | 79篇 |
1989年 | 57篇 |
1988年 | 56篇 |
1987年 | 44篇 |
1986年 | 34篇 |
1985年 | 54篇 |
1984年 | 59篇 |
1983年 | 28篇 |
1982年 | 38篇 |
1981年 | 35篇 |
1980年 | 28篇 |
1979年 | 18篇 |
1978年 | 19篇 |
1977年 | 12篇 |
1976年 | 12篇 |
1975年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 249 毫秒
1.
2.
Xiumei Jiang Xiaowei Zhang Patrick Gray Jiwen Zheng Timothy R. Croley Peter P. Fu 《journal of environmental science and health part c-environmental carcinogenesis & ecotoxicology reviews》2019,37(2):116-131
Gold nanoparticles (Au NPs) hold great promise in food, industrial and biomedical applications due to their unique physicochemical properties. However, influences of the gastrointestinal tract (GIT), a likely route for Au NPs administration, on the physicochemical properties of Au NPs has been rarely evaluated. Here, we investigated the influence of GIT fluids on the physicochemical properties of Au NPs (5, 50, and 100?nm) and their implications on intestinal epithelial permeability in vitro. Au NPs aggregated in fasted gastric fluids and generated hydroxyl radicals in the presence of H2O2. Cell studies showed that GIT fluids incubation of Au NPs affected the cellular uptake of Au NPs but did not induce cytotoxicity or disturb the intestinal epithelial permeability. 相似文献
3.
4.
5.
Rosario Gulias-Cañizo Anell Lagunes-Guillén Arturo González-Robles Erika Sánchez-Guzmán Federico Castro-Muñozledo 《Burns : journal of the International Society for Burn Injuries》2019,45(2):398-412
Background
Since recent reports have shown that (-)-Epigallocatechin-3-gallate (EGCG) could be used for treating proliferative and inflammatory disorders, we explored its use for the management of corneal chemical burns.Materials and methods
Initially, EGCG was assayed on the rabbit corneal epithelial cell line RCE1(5T5) to establish the best testing conditions, and to avoid unwanted outcomes in the experimental animals. Then, we studied its effects on cell proliferation, cell cycle progression and cell differentiation. Afterwards, we instilled EGCG in experimental grade II corneal alkali burns in mice, three times a day up to 21 days, and evaluated by slit lamp examination and histological sections of corneal epithelial, corneal endothelial and stromal edema, as well as the presence of inflammatory cells and neovascularization.Results
EGCG reduced cell growth and led to a decline in the proportion of proliferative cells in a concentration dependent manner. At 10 μM, EGCG promoted cell differentiation, an effect not related with apoptosis or cytotoxicity. When 10 μM EGCG was instilled in corneal alkali burns in mice three times a day up to 21 days, EGCG significantly reduced corneal opacity and neovascularization. The improved clinical appearance of the cornea was associated to a controlled epithelial growth; epithelial morphology was similar to that observed in normal epithelium and contrasted with the hyperproliferative, desquamating epithelium observed in control burn wounds. EGCG reduced corneal, stromal and endothelial edema, and wound inflammation.Conclusion
This work constitutes the first evidence for the use of EGCG in the acute phase of a corneal alkali burn, representing a possible novel alternative to improve patient outcomes as an add-on therapy. 相似文献6.
7.
《Surgical pathology clinics》2015,8(4):587-621
According to the current World Health Organization (WHO), renal cell carcinomas (RCCs) that primarily affect adults are classified into 8 major subtypes. Additional emerging entities in renal neoplasia have also been recently recognized and these are discussed in further detail by Mehra et al (Emerging Entities in Renal Neoplasia, Surgical Pathology Clinics, 2015, Volume 8, Issue 4). In most cases, the diagnosis of a RCC subtype can be based on morphologic criteria, but in some circumstances the use of ancillary studies can aid in the diagnosis. This review discusses the morphologic, genetic, and molecular findings in RCCs previously recognized by the WHO, and provides clues to distinction from each other and some of the newer subtypes of RCC. As prognosis and therapeutic options vary for the different subtypes of RCC, accurate pathologic distinction is critical for patient care. 相似文献
8.
Renal fibrosis and the origin of the renal fibroblast. 总被引:4,自引:0,他引:4
Many studies have determined that the extent of tubulointerstitialinvolvement, particularly fibrosis, correlates better with renalfunction than glomerular changes do, thus, the extent of tubulointerstitialdamage in any given renal biopsy has important implicationsfor the renal prognosis of the patient (summarized in [1]).Tubulointerstitial fibrosis is characterized by the accumulationof extracellular matrix components including collagen typesI, III, IV, proteoglycans and fibronectin. In recent years,much controversy has been created in the nephrology communityregarding the origin of matrix-producing cells in the kidney.Several possibilities exist, including activation of residentinterstitial fibroblasts, migrating haematopoietic or mesenchymalstem cells from the bone marrow, periadventitial cells and epithelialmesenchymaltransition (EMT) of tubular epithelial cells. This review summarizesrecent data indicating the possible origin of matrix-producingcells in the kidney, and illustrates from a clinical point of 相似文献
9.
【摘要】 目的 观察在生理和病理情况下,骨髓来源的干细胞(BMSC)能否分化成肾小管上皮细胞。 方法 绿色荧光蛋白(GFP)标记的C57BL/6转基因小鼠提供骨髓细胞。同种无荧光标记的C57BL/6小鼠100只分为正常对照组、全身照射组、缺血再灌注组、骨髓移植组、骨髓移植+缺血再灌注组。受体鼠的骨髓重建经血液常规检查和流式细胞仪检测确认,并采用荧光组织化学、免疫组织化学等方法观察绿色荧光标记的BMSC在受体鼠肾脏的分布及数量。 结果 全身致死剂量γ射线照射未造成小鼠肾脏组织结构和生理功能的明显改变。骨髓移植后第56、84天的受体鼠肾小管中有少量GFP阳性细胞的存在[(78.75±5.99)%、(79.58±4.60)%],激光共聚焦显微镜进一步证实这些细胞位于肾小管,并表达肾小管上皮细胞特异性的功能蛋白megalin。 结论 在生理和病理情况下,骨髓干细胞均可以向肾小管上皮细胞转分化,参与肾小管上皮细胞的更新,并且在急性肾小管坏死的病理条件下,骨髓干细胞的肾向转化率与肾脏受损程度有关。 相似文献
10.
What is the value of bcl-2 protein detection for histopathologists? 总被引:15,自引:0,他引:15